139 related articles for article (PubMed ID: 24118596)
1. Acquired factor V deficiency in a patient without evidence of a classical inhibitor.
Sosa IR; Ellery P; Mast A; Neff AT; Gailani D
Haemophilia; 2014 Jan; 20(1):e81-3. PubMed ID: 24118596
[No Abstract] [Full Text] [Related]
2. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
3. Successful management of transcatheter aortic valve implantation by platelet transfusions in a nonagenarian patient with severe autoimmune factor V deficiency.
Mouton C; Leroux L; Bonnet G; Seguy B; Lafargue A; Baulier G; Castet S; Fiore M
Ann Hematol; 2019 Aug; 98(8):1991-1992. PubMed ID: 30830247
[No Abstract] [Full Text] [Related]
4. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
[TBL] [Abstract][Full Text] [Related]
5. The potential value of thrombin generation assay in the diagnosis of FV inhibitors.
Désage S; Jousselme E; Le Quellec S; Lienhart A; Nougier C; Dargaud Y; Jourdy Y
Int J Lab Hematol; 2019 Oct; 41(5):e117-e120. PubMed ID: 30953579
[No Abstract] [Full Text] [Related]
6. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
7. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
8. Transient Factor V deficiency associated with Factor V-immunoglobulin complexes but without evidence of a classical inhibitor.
Cortier D; Van Dreden P; Adam M; Bironien R; François D; Vasse M
Thromb Res; 2016 Nov; 147():10-12. PubMed ID: 27664390
[No Abstract] [Full Text] [Related]
9. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Fujita Y; Nakazato T; Ito C; Masuda K; Osada Y; Aisa Y; Mori T
Ann Hematol; 2018 Oct; 97(10):2009-2010. PubMed ID: 29713749
[No Abstract] [Full Text] [Related]
10. An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy SB; Krakow EF; Fuller N; Tasneem S; Hayward CP
J Thromb Haemost; 2008 Feb; 6(2):395-7. PubMed ID: 18047547
[No Abstract] [Full Text] [Related]
11. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
12. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
Ahmadinejad M; Roushan N
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
[TBL] [Abstract][Full Text] [Related]
13. Acquired factor V inhibitor in systemic vasculitis.
Ciang CO; Leung MH
Int J Rheum Dis; 2012 Apr; 15(2):e19-22. PubMed ID: 22462428
[No Abstract] [Full Text] [Related]
14. Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
Taniwaki M; Katsutani S; Yamasaki M; Kawamoto K; Funaishi K; Matsumoto Y; Matsumoto N; Ohashi N; Hattori N
Ann Hematol; 2019 Aug; 98(8):1989-1990. PubMed ID: 30747247
[No Abstract] [Full Text] [Related]
15. Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy.
Takahashi H; Fuse I; Abe T; Yoshino N; Aizawa Y
Blood Coagul Fibrinolysis; 2003 Jan; 14(1):87-93. PubMed ID: 12544735
[TBL] [Abstract][Full Text] [Related]
16. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary factor V deficiency and factor V inhibitor without bleeding. Rare causes of pathological screening tests of coagulation].
Borucki K; Töpfer G; Hartung KJ; Lutze G
Hamostaseologie; 2007 Aug; 27(3):188-90. PubMed ID: 17694226
[TBL] [Abstract][Full Text] [Related]
18. Acquired factor V inhibitor.
Teh PP; Grigoriadis G; Salem H
Intern Med J; 2010 Sep; 40(9):667-8. PubMed ID: 20840214
[No Abstract] [Full Text] [Related]
19. Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays.
Perdekamp MT; Rubenstein DA; Jesty J; Hultin MB
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):593-7. PubMed ID: 16988558
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment with rituximab in a patient with an acquired factor V inhibitor.
Lebrun A; Leroy-Matheron C; Arlet JB; Bartolucci P; Michel M
Am J Hematol; 2008 Feb; 83(2):163-4. PubMed ID: 17849464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
